1. Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs

   • Marieke G. G. Sturkenboom
   • Anne-Grete Märtson
   • Jan-Willem C. Alffenaar

   Review Article Open access 06 March 2021 Pages: 685 - 710

   

2. Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections

   • Jan-Willem Alffenaar
   • Anne-Grete Märtson
   • Charles A. Peloquin

   Review Article Open access 10 March 2021 Pages: 711 - 725

   

3. A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients

   • Philip Roland Selby
   • Sepehr Shakib
   • Jason A. Roberts

   Systematic Review 30 January 2021 Pages: 727 - 739

   

4. Fetal Physiologically Based Pharmacokinetic Models: Systems Information on Fetal Cardiac Output and Its Distribution to Different Organs during Development

   • Khaled Abduljalil
   • Xian Pan
   • Masoud Jamei

   Original Research Article 24 January 2021 Pages: 741 - 757

   

5. Pharmacokinetics of Roxadustat: A Population Analysis of 2855 Dialysis- and Non-Dialysis-Dependent Patients with Chronic Kidney Disease

   • Dinko Rekić
   • Virginie Kerbusch-Herben
   • Bengt Hamrén

   Original Research Article 24 January 2021 Pages: 759 - 773

   

6. Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP)

   • Julie M. Janssen
   • Kristel Van Calsteren
   • Frederic C. H. Amant

   Original Research Article 28 January 2021 Pages: 775 - 784

   

7. Oxycodone Effect on Pupil Constriction in Recreational Opioid Users: A Pharmacokinetic/Pharmacodynamic Meta-Analysis Approach

   • Anna Dari
   • Stefan Buller
   • Jan Freijer

   Original Research Article 30 January 2021 Pages: 785 - 794

   

8. Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir

   • Xiaomei I. Liu
   • Jeremiah D. Momper
   • André Dallmann

   Original Research Article 02 February 2021 Pages: 795 - 809

   

9. Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease

   • Wan Sun
   • Blair Fennimore
   • Richard A. Lirio

   Original Research Article Open access 05 February 2021 Pages: 811 - 818

   

10. Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine

    • Max Tsai
    • Emel Serap Monkul Nery
    • Paul Winner

    Original Research Article Open access 10 February 2021 Pages: 819 - 828

    

11. Comment on “Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6”

    • Dario Cattaneo
    • Mario Corbellino
    • Cristina Gervasoni

    Letter to the Editor 17 April 2021 Pages: 829 - 831

12. Authors’ Reply to Cattaneo et al.: “Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6”

    • Pier Giorgio Cojutti
    • Angela Londero
    • Federico Pea

    Letter to the Editor 17 April 2021 Pages: 833 - 834